Hydroxychloroquine tablets bulk supplier for pharma manufacturers

Hydroxychloroquine Tablets 200 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 200 mg

Reference Brands: Plaquenil(US & EU)

Category: Arthritis

Hydroxychloroquine inhibits antigen processing and immune activation, reducing inflammation and autoimmune responses. It effectively manages rheumatoid arthritis and lupus, providing benefits like symptom relief, decreased disease progression, and improved quality of life. Its safety profile and oral administration make it a valuable therapy for autoimmune conditions.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Hydroxychloroquine tablets are approved in the EU and US for treating rheumatoid arthritis and lupus. In the EU, Sanofi’s Plaquenil and generics are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data and biosimilarity assessments. Both regions require detailed dossiers for initial approval and ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for hydroxychloroquine tablets, ensuring adherence to European and American standards for safe, effective treatment of autoimmune diseases.

Hydroxychloroquine Tablets — third party manufacturing & bulk supply

Hydroxychloroquine Tablets 200 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Hydroxychloroquine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Hydroxychloroquine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Hydroxychloroquine Tablets →

Back to Listing

Frequently Asked Questions

Hydroxychloroquine tablets is listed as Tablets in 200 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Hydroxychloroquine tablets is referenced against Plaquenil(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.